01363nam 2200361Ia 450 991069911180332120230902162255.0(CKB)5470000002400782(OCoLC)466868919(EXLCZ)99547000000240078220091118d2009 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] postmarketing studies and clinical trials, implementation of section 505(o) of the Federal Food, Drug, and Cosmetic ActRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research :Center for Biologics Evaluation and Research,[2009]1 online resource (13 pages)"Draft guidance.""Drug safety.""July 2009."Guidance for industry Clinical trialsGovernment policyUnited StatesClinical trialsGovernment policyCenter for Drug Evaluation and Research (U.S.)Center for Biologics Evaluation and Research (U.S.)GPOGPOBOOK9910699111803321Guidance for industry3434577UNINA